The £14.25m Engineered Genetic Control Systems for Advanced Therapeutics Hub will establish improved gene therapy techniques for patients with serious conditions.
It will create new biological tools to improve the effectiveness and safety of gene therapies, testing them in cancers, cardiovascular disease and rare diseases.
The hub, led by Professor Susan Rosser, will bring together a multidisciplinary team from the Universities of Edinburgh and Oxford, Imperial College London and the CRUK Scotland Institute.
Research hubs
The new centre is one of six announced as part of a £100m UK-wide investment in engineering biology by UK Research and Innovation (UKRI).
Funding for the new hubs is provided by the UKRI Technology Missions Fund, with support from the Biotechnology and Biological Sciences Research Council (BBSRC).
The hubs will be funded for five years and involve multiple academic and industrial partners
